Literature DB >> 24761852

Experimental study on residual tumor angiogenesis after cryoablation.

Chun-Hua Ma1, Rong Jiang, Jin-Duo Li, Bin Wang, Li-Wei Sun, Yuan Lv.   

Abstract

OBJECTIVE: To explore the mechanism and significance of tumor angiogenesis by observing changes of micro-vessel density (MVD) and expression of vascular endothelial growth factor (VEGF) in residual tumor tissues after cryoablation.
MATERIALS AND METHODS: A total of 18 nude mice xenograft models with transplanted lung adenocarcinoma cell line A549 were established and randomly divided into 3 groups when the maximum diameter of tumor reached 1 cm: control, cisplatin (DDP) and cryoablation. The nude mice were sacrificed after 21-d cryoablation to obtain the tumor tissues. Then immunohistochemistry was applied to determine MVD and the expression of VEGF in tumor tissues.
RESULTS: The tumor volumes of control group, DDP group and cryoablation group were 1.48 ± 0.14 cm3, 1.03 ± 0.12 cm3 and 0.99 ± 0.06 cm3 respectively and the differences were significant (P < 0.01), whereas MVD values were 21.1 ± 0.86, 24.7 ± 0.72 and 29.2 ± 0.96 (P < 0.01) and the positive expression rates of VEGF were 36.2 ± 1.72%, 39.0 ± 1.79% and 50.8 ± 2.14% (P < 0.01), respectively, showing that MVD was proportional to the positive expression of VEGF (r = 0.928, P < 0.01).
CONCLUSIONS: Cryoablation can effectively inhibit tumor growth, but tumor angiogenesis significantly increases in residual tumors, with high expression of VEGF playing an important role in the residual tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24761852     DOI: 10.7314/apjcp.2014.15.6.2491

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.

Authors:  Alp Tuna Beksac; Gerant Rivera-Sanfeliz; Catherine A Dufour; Unwanaobong Nseyo; Zachary Hamilton; Sean W Berquist; Abd-elRahman Hassan; Omer A Raheem; Song Wang; Robert W Wake; Robert E Gold; Ithaar H Derweesh
Journal:  World J Urol       Date:  2016-08-02       Impact factor: 4.226

2.  Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma.

Authors:  Xin Li; Jiahua Xu; Xiaoqiang Gu; Ling Chen; Qing Wu; Hongwei Li; Haoran Bai; Jinzu Yang; Jianxin Qian
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.